JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 17 No. 7 633-638
© 1976 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loberg, M. D.
Right arrow Articles by Faith, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loberg, M. D.
Right arrow Articles by Faith, W.

Development of New Radiopharmaceuticals Based on N-Substitution of Iminodiacetic Acid

Michael D. Loberg, Malcolm Cooper, Elizabeth Harvey, Patrick Callery and William Faith

University of Maryland, Baltimore, Maryland

Correspondence: For reprints contact: M. D. Loberg, Div. of Nuclear Medicine, University of Maryland Hospital, 22 S. Greene St., Baltimore, MD 21201.

ABSTRACT

A new approach to radiopharmaceutical design is demonstrated, in which small chelating groups capable of binding gamma-emitting radiometals are attached to biologically active molecules, thus producing radiopharmaceuticals based on bifunctional drug and biochemical analogs. The chelating group iminodiacetic acid has been evaluated for this role by examining two N-substituted iminodiacetic acids: methyliminodiacetic acid (MIDA) and N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid (HIDA). Radiochemical and biologic studies showed that both agents were obtained in high radiochemical purity, were stable in vitro and in vivo, and possessed biologic distributions governed almost exclusively by the N-substituted group. These characteristics of 99mTc-labeled N-substituted iminodiacetic acids, prepared using an "instant kit" method, provide the basis for a valuable new class of radiopharmaceuticals based on bifunctional drug and biochemical analogs.




This article has been cited by other articles:


Home page
JNMHome page
R. J. Bennink, S. Dinant, D. Erdogan, B. H. Heijnen, I. H. Straatsburg, A. K. van Vliet, and T. M. van Gulik
Preoperative Assessment of Postoperative Remnant Liver Function Using Hepatobiliary Scintigraphy
J. Nucl. Med., June 1, 2004; 45(6): 965 - 971.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1976 by the Society of Nuclear Medicine.